Japan, Aug. 31 -- GENMAB AS has got intellectual property rights for 'LINKERS, DRUG LINKERS, CONJUGATES THEREOF, AND METHODS OF USING THE SAME.' Other related details are as follows:
Application Number: JP,2025-134578
Category (FI): A61K31/4745,A61K31/704,A61K47/60,A61K31/537,A61K38/08,A61K38/07,A61K45/00,A61K47/65,A61K47/62,C07K4/00,C07K5/09,C07K16/00,C07K5/10,A61K51/10,100,A61K51/08,100,A61K51/06,100,A61K39/395@T,A61P35/00,A61K39/395@U,A61K39/395@D,A61K47/68,A61K33/241,A61K33/38,A61K33/34,A61K33/242,A61K33/24,A61K33/244,A61K33/243,A61K31/519,A61K31/517,A61P37/02,A61K31/5365
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Aug. 13, 2025
Publication Date: Nov. 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
